ARMH1

ARMH1 is a regulator of leukemia cell proliferation and migration that links cell cycle control to mitochondrial oxidative metabolism (PMID:39703843). ARMH1 acts upstream of the cell cycle regulators CDCA7 and EZH2, with its knockdown downregulating both, and it physically associates with the epigenetic regulator EZH2 (PMID:39703843). ARMH1 loss also reduces CPT1A expression, ATP production, and oxygen consumption, and CPT1A inhibition reciprocally lowers ARMH1, defining a feedback relationship between ARMH1 and mitochondrial fatty acid metabolism (PMID:39703843). Beyond these findings in leukemia cell lines, no further mechanistic detail — including the molecular activity, domain function, or mechanism by which ARMH1 controls these targets — has been characterized in the available corpus.

1. 2024 Medium

   Whether ARMH1 has any role in cancer cell behavior was unknown; loss- and gain-of-function established it as a positive regulator of proliferation and migration acting upstream of cell cycle regulators.

   Evidence ARMH1 knockdown/overexpression with proliferation and migration assays plus bulk RNA-seq in leukemia cell lines

   PMID:39703843

   Open questions at the time

   • Mechanism by which ARMH1 controls CDCA7 and EZH2 expression is not defined
   • Single lab, single cancer context (leukemia)
   • No in vivo validation of the proliferation/migration phenotype
2. 2024 Medium

   To address how ARMH1 connects to epigenetic cell cycle control, a physical interaction with EZH2 was tested, establishing ARMH1 as an EZH2-associated protein.

   Evidence Co-immunoprecipitation in leukemia cell lines

   PMID:39703843

   Open questions at the time

   • Single Co-IP without reciprocal validation
   • Interaction interface and whether it is direct are unknown
   • Functional consequence of the ARMH1–EZH2 interaction not dissected
3. 2024 Medium

   Whether ARMH1 influences cellular metabolism was unaddressed; perturbation experiments linked it to mitochondrial oxidative function and CPT1A in a reciprocal regulatory loop.

   Evidence ARMH1 knockdown with Seahorse mitochondrial assay and pharmacological CPT1A inhibition in leukemia cell lines

   PMID:39703843

   Open questions at the time

   • Molecular mechanism of the ARMH1–CPT1A reciprocal regulation is unknown
   • Whether the metabolic effect is direct or secondary to the proliferation phenotype is unresolved

• The biochemical activity of ARMH1 and how it mechanistically connects EZH2-dependent cell cycle control to mitochondrial fatty acid metabolism remain unknown.
• No molecular activity or enzymatic function established
• No structural model or domain-level mechanism
• Subcellular localization not determined in the corpus